Medline Adds Award-winning IDENTI Medical Sensing Solutions to its Supply Chain Portfolio

Offers first wireless weight-based PAR bins in the U.S.

Responding to increased healthcare provider demand for digital and scalable inventory management solutions, Medline has enhanced its supply chain optimization (SCO) portfolio with a new partnership with IDENTI Medical.

A dynamic and global leader in point-of-use data sensing solutions, IDENTI Medical designs, develops and produces advanced data collection solutions for surgery, procedure and clean supply room settings.  Last year, Netanya-headquartered IDENTI ranked in the top 100 fastest growing companies in Israel, while its SNAP & GO™ image recognition technology won the 2022 Frost & Sullivan Best New Product Innovation Award.

SNAP & GO maximizes the efficiencies in ORs and procedure rooms, while increasing patient safety by digitally recording product information and usage at the point of use. Complete unique device identification tracking is recorded directly into the patient’s electronic file, saving time for busy clinical staff and achieving full data and charge capture in seconds.

In addition, IDENTI recently launched the first-of-its-kind in the U.S. wireless, weight-based and self-requisition PAR bin– garnering major industry interest and accolades. The bin’s wireless feature marks the next generation of PAR supplies management as the bin are completely wireless and can be placed wherever most needed.

“As prime vendor and preferred supplier to top healthcare systems and providers around the U.S., Medline provides the resources, distribution programs and access to technology to enable end-to-end inventory models of visibility – from distribution centers to point-of-use,” said John Ramirez, Medline senior director of supply chain. “IDENTI’s global success, expertise and technology will go a long way in helping us deliver impactful supply chain solutions in the healthcare industry.”

IDENTI is also well known globally for its clinician-friendly solutions for tissue and implant tracking, medical supplies replenishment and management systems for controlled substances and narcotics – boosting patient safety and improving business processes.

“At our core, we apply state-of-the-art technology including AI, machine learning, RFID and image recognition technology to help providers achieve more control over their medical inventory and improve patient outcomes,” said Shlomo Matityaho, chief executive officer of IDENTI, “And, we’re thrilled to have an agile and forward-thinking partner in Medline, whose commitment to bring forward to its customers the top healthcare tech and resources in the world is clearly driving Medline’s remarkable growth.” More here.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.